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Abstract Background: Tetanus is 
characterized by increased muscle 
tone and spasms caused by the neu-
rotoxin, tetanospasmin. Manage-
ment principles include wound  
debridement, antibiotic therapy, 
neutralize circulating toxins, spasm 
control, supportive care and initia-
tion of active immunization. 
Aim: To highlight the use of oral 
baclofen in tetanus treatment. 
Method: The management of a pe-
culiar case of tetanus was high-
lighted. Medscape and Pubmed 
were also searched for some related 
literatures. 
Case Presentation: A nine year old 
boy with antecedent history of dirty 
wound presented with trismus and 
generalized spasms of one week 
duration. Though fully conscious, 
he could neither talk nor eat. He 
was from a poor socio-economic  
background. 
He had wound debridement, I.V 
metronidazole for seven days, a 
cocktail of diazepam infusion 5mg/
kg/day, I.V chlorpromazine 25mg 
12hourly and I.M phenobarbitone 
for 14 days. Five days into treat-
ment the spasms stopped but tris-
mus persisted up to the third week. 
By this time the maximal inter-
incisors distance was 0.5cm. Ba-
clofen syrup was commenced at 
10mg daily. Five days later the 
maximal inter-incisors’ distance 
was 1.0cm, and a week later it was 
2.5cm. By the second week of oral 
baclofen there was complete resolu-
tion of trismus and recovery of 
speech. 
Conclusion: This report suggests 
the need for further studies on the 
use of enteral baclofen during teta-
nus. Although intratheccal baclofen 
is in use, during recovery from teta-
nus, treatment with oral baclofen 
may reduce morbidity.  
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Introduction  
 
Tetanus results from intoxication by Clostridium tetani. 
It is characterized by increased muscle tone and spasms 
caused by the neurotoxin, tetanospasmin. 
The clinical forms of the disease include generalized, 
local, neonatal and cephalic tetanus. In most cases it  
occurrence is in neonates and children.1,2 The principles 
of treatment include debridement of infectious tissues at 
the portal of entry, use of appropriate antibiotic to kill 
clostridium tetani, neutralization of circulating toxins, 
control of spasms, supportive care, and initiation of ac-
tive immunization. In severe cases mechanical ventila-
tion and intensive care may be needed.3  Much is known 
of the role of intratheccal baclofen in its therapy but 
little has been documented on possible enteral use of the 
drug in treating tetanus. 
We report a boy from an urban Nigerian slum with pro-
longed trismus following tetanus. The trismus abated 




A nine year old boy presented with trismus and  
generalized spasms of one week duration. He sustained 
an injury to his jaw from a dirty stick while playing a 
week prior to trismus. Local concoction and menthola-
tum were applied to the wound at home. There was pu-
rulent discharge from the wound. He could neither talk
nor eat but was conscious throughout the illness. He was 
from a poor socio-economic background. 
 
At presentation there was a discharging wound from the 
left side of the jaw. He had trismus, risus sardonicus and 
intermittent provoked spasms. The vital signs were nor-
mal. The assessment was moderate tetanus. The septic
wound was debrided and managed, and it healed after 
seven days. He was given anti-tetanus serum 10,000 
units stat and intravenous metronidazole 200mg eight-
hourly for seven days. He also had a cocktail of titrated 
intravenous diazepam 5mg/kg/day, intramuscular phe-
nobarbitone 7.5mg/kg/day and intravenous chlorpro-
mazine 25mg every 12 hours for fourteen days. Five 
days into treatment the spasms stopped, but by the third 
week of therapy there was no improvement in trismus. 
By this time the maximal inter-incisors distance was 
0.5cm, he was spasm free,was fully conscious, ambulant 
and could interact with others except that he could nei-
ther talk nor eat solids. 
 
He was then started on oral baclofen (compounded into 
syrup) at 10mg daily. Five days later the maximal inter-
incisors’ distance was 1.0cm, and a week later it was 
2.5cm. There was improvement in speech and by the 
second week of oral baclofen there was complete resolu-







The relationship between poor wound management cum 
dirty environmental conditions and tetanus has long 
been established.4 
 
This in part explains the differences in the burden of 
tetanus prevalence and mortality between developed and 
developing countries.5 The disease is prevalent in devel-
oping countries because of low coverage of tetanus vac-
cination amongst pregnant women and children.6-8 It 
was reported in separate Nigerian studies that neonatal 
tetanus is a reasonable contributor to newborn morbidity 
and mortality in some parts of the country.9-11 
Deep penetrating dirty wounds such as noted in this  
report favour the occurrence of tetanus. The first, unmis-
takable feature of tetanus in most cases, as in this case is 
trismus due to masseter muscle spasm.12 
 
Nuchal rigidity and dysphagia produce the scornful fa-
cial appearance termed risus sardonicus. Opisthotonus 
may occur with severe and frequent spasms. Sound, 
light or touch can trigger these spasms. The patient re-
mains conscious, but unfortunately in agony because of 
the fear of the next spasm. Cranial nerve palsy and f cial 
spasms are features of cephalic tetanus.13 
For spasm control, centrally acting and skeletal muscle 
relaxants are options. The former has the advantage of 
tranquilizing the patient while controlling spasms. How-
ever, the need for respiratory support in some cases ne-
cessitates caution in their use. Magnesium sulphate is 
increasingly being used as an option in controlling teta-
nus muscle spasm 14-16 and intratheccal baclofen is also 
used to produce skeletal muscle relaxation and to control 
spasms during the disease.17,18 Guglani et al have used  
enteral baclofen to control spasms that was unresponsive 






The successful treatment of prolonged trismus following 
tetanus in this report indicates the need for further stud-
ies on the use of enteral baclofen in the treatment of 
mild to moderate tetanus. Although intratheccal baclofen 
is currently in use, in less severe cases early commence-
ment of enteral baclofen may reduce the severity and 
morbidity of the disease. Again, oral baclofen is  
non-invasive and it is available in poor countries.  
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